Tolman et al., 1969 - Google Patents
Pyrrolopyrimidine nucleosides. III. Total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivativesTolman et al., 1969
- Document ID
- 14552682078717020034
- Author
- Tolman R
- Robins R
- Townsend L
- Publication year
- Publication venue
- Journal of the American Chemical Society
External Links
Snippet
The structures of toyocamycin and sangivamycinhave been unequivocally established as 4- amino-5-cyano-7-^-D-ribofuranosyl) pyrrolo [2, 3-d] pyrimidine (1) and 4-amino-5- carboxamido-7-(PD-ribofuranosyl) pyrrolo [2, 3-ii] pyrimidine (2), respectively. The total …
- 239000002777 nucleoside 0 title abstract description 24
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tolman et al. | Pyrrolopyrimidine nucleosides. III. Total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives | |
EP0286028B1 (en) | Derivatives of disazapurine nucleosides, process for their preparation and their use in the sequence analysis of nucleic acids and as antiviral agents | |
Lim et al. | Synthesis of" 9-deazaguanosine" and other new pyrrolo [3, 2-d] pyrimidine C-nucleosides | |
Krenitsky et al. | 3'-Amino-2', 3'-dideoxyribonucleosides of some pyrimidines: synthesis and biological activities | |
KR20030032944A (en) | Pyrido [2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides | |
US4140851A (en) | Synthesis and antitumor activity of 2,4,5-trisubstituted-pyrrolo2,3-d]-pyrimidine nucleosides | |
AU769578B2 (en) | Pyrrolo(2,3-d)pyrimidine nucleoside analogs | |
Rousseau et al. | The synthesis of 4-amino-β-D-ribofuranosylimidazo [4, 5-c] pyridine (3-deazaadenosine) and related nucleotides | |
Sanghvi et al. | Antitumor and antiviral activity of synthetic. alpha.-and. beta.-ribonucleosides of certain substituted pyrimido [5, 4-d] pyrimidines: a new synthetic strategy for exocyclic aminonucleosides | |
Tolman et al. | Pyrrolopyrimidine nucleosides II. the total synthesis of 7‐β‐D‐ribofuranosylpyrrolo [2, 3‐d] pyrimidines related to toyocamycin | |
Kini et al. | Synthesis and antiviral activity of certain guanosine analogs in the thiazolo [4, 5-d] pyrimidine ring system | |
Kazimierczuk et al. | Total synthesis of certain 2-, 6-mono-and 2, 6-disubstituted-tubercidin derivatives. Synthesis of tubercidin via the sodium salt glycosylation procedure | |
Khandazhinskaya et al. | Novel fleximer pyrazole-containing adenosine analogues: Chemical, enzymatic and highly efficient biotechnological synthesis | |
Kondo et al. | Synthesis of 5-Methyltubercidin and Its α-Anomer via Condensation of the Anion of 4-Methoxy-5-methyl-2-methylthiopyrrolo [2, 3-d] pyrimidine and 2, 3, 5-Tri-O-benzyl-d-ribofuranosyl Bromide | |
Garner et al. | Synthesis of 2-aminopurine nucleosides via regiocontrolled glycosylation | |
Seela et al. | Synthesis of 6-Substituted 7-Carbapurine 2′, 3′-Dideoxynucleosides: Solid-Liquid Phase-Transfer Glycosylation of 4-Chloropyrrolo [2, 3-d] pyrimidine and Deoxygenation of its 2′-Deoxyribofuranoside | |
Seela et al. | Regioselective syntheses of 7-halogenated 7-deazapurine nucleosides related to 2-amino-7-deaza-2′-deoxyadenosine and 7-deaza-2′-deoxyisoguanosine | |
Anderson et al. | Pyridopyrimidines. 7. Ribonucleosides structurally related to the antitumor antibiotic sangivamycin | |
Cottarn et al. | A convenient Synthesis of 6-amino-1-β-D-ribofuranosylpyrazolo [3, 4-d] Pyrimidin-4-one and related 4, 6-disubstltuted pyrazodopyrimidine nucleosldes | |
Chung et al. | Synthesis of certain [6: 5: 6] linear tricyclic nucleosides as potential antitumor agents | |
Chu et al. | Nucleosides. 117. Synthesis of 4‐oxo‐8‐(β‐D‐ribofuranosyl)‐3H‐pyrazolo [1, 5‐a]‐1, 3, 5‐triazine (OPTR) via 3‐amino‐2N‐carbamoyl‐4‐(β‐D‐ribofuranosyl) pyrazole (ACPR) derivatives | |
UEDA et al. | Synthesis and Optical Properties of 2, 3-Dideoxy-D-erythro-hex-2-enopyranosyl Nucleosides (Nucleosides and Nucleotides. LXII) | |
Cristalli et al. | 3, 7-Dideazapurine nucleosides. Synthesis and antitumor activity of 1-deazatubercidin and 2-chloro-2'-deoxy-3, 7-dideazaadenosine | |
SEELA et al. | 8-Aza-7-deaza-2', 3'-dideoxyadenosine: synthesis and conversion into allopurinol 2', 3'-dideoxyribofuranoside | |
Eger et al. | Synthesis of pyrrolo [2, 3‐d] pyrimidine ribosides and their potential in chemotherapeutics |